Saikosaponin-d inhibits proliferation of human undifferentiated thyroid carcinoma cells through induction of apoptosis and cell cycle arrest

European Review for Medical and Pharmacological Sciences

Volumn 18, Issue 17, 2014, Pages 2435-2443

  Liu, R Y ^a   Li, J P ^b  

^a Shanghai Medical Centre   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Apoptosis; Human undifferentiated thyroid carcinoma; Proliferation; Saikosaponin d

Indexed keywords

CYCLIN D1; CYCLIN DEPENDENT KINASE 2; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P21; PROTEIN P53; SAIKOSAPONIN D; ANTINEOPLASTIC AGENT; OLEANOLIC ACID; SAIKOSAPONIN; SAPONIN;

ANAPLASTIC THYROID CANCER; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; CARCINOMA CELL; CELL PROLIFERATION; CONTROLLED STUDY; DOSE RESPONSE; DOWN REGULATION; EXPERIMENTAL CARCINOGENESIS; FLOW CYTOMETRY; G1 PHASE CELL CYCLE CHECKPOINT; HUMAN; HUMAN CELL; IN VIVO STUDY; MALE; MOUSE; MTT ASSAY; NONHUMAN; PROTEIN EXPRESSION; THYROID CARCINOMA; TUMOR VOLUME; TUMOR XENOGRAFT; UNDIFFERENTIATED CARCINOMA; UNDIFFERENTIATED THYROID CARCINOMA; UPREGULATION; WESTERN BLOTTING; ANALOGS AND DERIVATIVES; ANIMAL; CELL CYCLE; CELL CYCLE CHECKPOINT; DRUG EFFECTS; DRUG SCREENING; NUDE MOUSE; PATHOLOGY; THYROID NEOPLASMS; TUMOR CELL LINE;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CELL CYCLE; CELL CYCLE CHECKPOINTS; CELL LINE, TUMOR; CELL PROLIFERATION; HUMANS; MALE; MICE; MICE, NUDE; OLEANOLIC ACID; SAPONINS; THYROID NEOPLASMS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84928392402     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. ITO Y, MIYAUCHI A. Prognostic factors and therapeutic strategies for differentiated carcinomas of the thyroid. Endocr J 2009;56:177-192.
2. MACHENS A, HOLZHAUSEN HJ, DRALLE H. The prognostic value of primary tumor size in papillary and follicular thyroid carcinoma. Cancer 2005;103:2269-2273.
3. HUGHES DT, LAIRD AM, MILLER BS, GAUGER PG, DOHERTY GM. Reoperative lymph node dissection for recurrent papillary thyroid cancer and effect on serum thyroglobulin. Ann Surg Oncol 2012;19:2951-2957.
4. SOARES P, LIMA J, PRETO A, CASTRO P, VINAGRE J, CELESTINO R, COUTO J P, PRAZERES H, ELOY C, MÁXIMO V, SOBRINHO-SIMÕES M. Genetic alterations in poorly differentiated and undifferentiated thyroid carcinomas. Curr Genomics 2011;12:609-617.
5. NILUBOL N, ZHANG L, KEBEBEW E. Multivariate analysis of the relationship between male sex, disease-specific survival, and features of tumor aggressiveness in thyroid cancer of follicular cell origin. Thyroid 2013;23:695-702.
6. LI P, GONG Y, ZU N, LI Y, WANG B, SHIMIZU F. Therapeutic mechanism of Saikosaponin-d in anti-Thy1 mAb 1-22-3-induced rat model of glomeru-lonephritis. Nephron Exp Nephrol 2005;101:e111-e118.
7. LU CN, YUAN ZG, ZHANG XL, YAN R, ZHAO YQ, LIAO M, CHEN JX. Saikosaponin a and its epimer saikos-aponin d exhibit anti-inflammatory activity by suppressing activation of NF-kB signaling pathway. Int Immunopharmacol 2012;14:121-126.
8. MAN S, GAO W, ZHANG Y, HUANG L, LIU C. Chemical study and medical application of saponins as anti-cancer agents. Fitoterapia 2010;81:703-714.
9. WANG Q, ZHENG XL, YANG L, SHI F, GAO LB, ZHONG YJ, SUN H, HE F, LIN Y, WANG X. Reactive oxygen species-mediated apoptosis contributes to chemosensitization effect of saikosaponins on cisplatin-induced cytotoxicity in cancer cells. J Exp Clin Cancer Res 2010;29:159.
10. LU XL, HE SX, REN MD, WANG YL, ZHANG YX, LIU EQ. Chemopreventive effect of saikosaponin-d on diethylinitrosamine-induced hepatocarcinogene-sis: involvement of CCAAT/enhancer binding protein beta and cyclooxygenase-2. Mol Med Rep 2012;5:637-644.
11. WONG VK, ZHANG MM, ZHOU H, LAM KY, CHAN PL, LAW CK, YUE P Y, LIU L. Saikosaponin-d enhances the anticancer potency of TNF-alpha via overcoming its undesirable response of activating NF-Kappa B signalling in cancer cells. Evid Based Complement Alternat Med 2013;2013:745295.
12. WONG VK, ZHOU H, CHEUNG SS, LI T, LIU L. Mechanistic study of saikosaponin-d (Ssd) on suppression of murine T lymphocyte activation. J Cell Biochem 2009;107:303-315.
13. YING ZL, LI XJ, DANG H, WANG F, XU XY. Saikos-aponin-d affects the differentiation, maturation and function of monocyte-derived dendritic cells. Exp Ther Med 2014;7:1354-1358.
14. TETZLAFF MT, LIU A, XU X, MASTER SR, BALDWIN DA, TOBIAS JW, LIVOLSI VA, BALOCH ZW. Differential expression of miRNAs in papillary thyroid carcinoma compared to multinodular goiter using formalin fixed paraffin embedded tissues. Endocr Pathol 2007;18:163-173.
15. KONDO T, EZZAT S, ASA SL. Pathogenetic mechanisms in thyroid follicular-cell neoplasia. Nat Rev Cancer 2006;6:292-306.
16. PANG M, WANG ZL, GAO CL, QU P, LI HD. Characterization of apoptotic changes induced by yesso-toxin in the Bel7402 human hepatoma cell line. Mol Med Rep 2011;4:547-552.
17. GUO LD, CHEN XJ, HU YH, YU ZJ, WANG D, LIU JZ. Curcumin inhibits proliferation and induces apop-tosis of human colorectal cancer cells by activating the mitochondria apoptotic pathway. Phytother Res 2013;27:422-430.
18. HAINAUT P, PLYMOTH A. Targeting the hallmarks of cancer: towards a rational approach to next-generation cancer therapy. Curr Opin Oncol 2013;25:50-51.
19. HSU YL, KUO PL, LIN CC. The proliferative inhibition and apoptotic mechanism of Saikosaponin D in human non-small cell lung cancer A549 cells. Life Sci 2004;75:1231-1242.
20. HSU YL, KUO PL, CHIANG LC, LIN CC. Involvement of p53, nuclear factor kappaB and Fas/Fas ligand in induction of apoptosis and cell cycle arrest by saikosaponin d in human hepatoma cell lines. Cancer Lett 2004;213:213-221.
21. HU W, GE Y, OJCIUS DM, SUN D, DONG H, YANG X F, YAN J. p53 signalling controls cell cycle arrest and caspase-independent apoptosis in macrophages infected with pathogenic Leptospira species. Cell Microbiol 2013;15:1642-1659.
22. FAN S, QI M, YU Y, LI L, YAO G, TASHIRO S, ONODERA S, IKEJIMA T. P53 activation plays a crucial role in silibinin induced ROS generation via PUMA and JNK. Free Radic Res 2012;46:310-319.
23. PIRNGRUBER J, JOHNSEN SA. Induced G1 cell-cycle arrest controls replication-dependent histone mR-NA 3' end processing through p21, NPAT and CDK9. Oncogene 2010;29:2853-2863.
24. CHEN XZ, CAO ZY, CHEN TS, ZHANG YQ, LIU ZZ, SU YT, LIAO LM, DU J. Water extract of Hedyotis Diffusa Willd suppresses proliferation of human HepG2 cells and potentiates the anticancer efficacy of low-dose 5-fluorouracil by inhibiting the CDK2-E2F1 pathway. Oncol Rep 2012;28:742-748.
25. GRILLO M, BOTT MJ, KHANDKE N, MCGINNIS J P, MIRANDA M, MEYYAPPAN M, ROSFJORD EC, RABINDRAN SK. Validation of cyclin D1/CDK4 as an anticancer drug target in MCF-7 breast cancer cells: Effect of regulated overexpression of cyclin D1 and siRNA-mediated inhibition of endogenous cyclin D1 and CDK4 expression. Breast Cancer Res Treat 2006;95:185-194.
26. FANG Y, CAO Z, HOU Q, MA C, YAO C, LI J, WU XR, HUANG C. CyclinD1 down regulation contributes to an-ticancer effect of isorhapontigenin onhuman bladder cancer cells. Mol Cancer Ther 2013;12:1492-1503.